Our history and milestones
2021
April – Obtained CE Marking for the Eyenable® IOL.
August – Initiated clinical trial for Eyedeal®, a next generation IOL.
2020
May – Obtained “Special Review Procedure for Innovative Medical Devices” status from the NMPA.
2019
January – Obtained “Academician Expert Workstation” status.
October – Initiated clinical trial for Eyenable® IOL.
November – Established “Postdoctoral Innovation Base”.
2017
July – Received prestige grant of “National Key R&D Program”.
2015
January – Registered and established Xi’an Eyedeal Medical Technology Co., Ltd.
June – Completed a GMP facility with full function of R&D, manufacturing and operation.